Why is it necessary to improve COVID-19 vaccination coverage in older people? How to improve the vaccination coverage?
In accordance with the COVID-19 surveillance data from Hong Kong, over 95% fatal cases were elderly patients aged ≥60 years, and the median age of the dead cases was 86 years in the fifth COVID-19 wave. COVID-19 case fatality rates increased with age, vaccinations offered notable protection against...
Gespeichert in:
Veröffentlicht in: | Human vaccines & immunotherapeutics 2023-08, Vol.19 (2), p.2229704-2229704 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2229704 |
---|---|
container_issue | 2 |
container_start_page | 2229704 |
container_title | Human vaccines & immunotherapeutics |
container_volume | 19 |
creator | Zhu, Ke-Wei |
description | In accordance with the COVID-19 surveillance data from Hong Kong, over 95% fatal cases were elderly patients aged ≥60 years, and the median age of the dead cases was 86 years in the fifth COVID-19 wave. COVID-19 case fatality rates increased with age, vaccinations offered notable protection against COVID-19 death, and the protection was enhanced as the doses of vaccinations increased. The data fully demonstrated that elderly people were the main group of victims in the COVID-19 pandemic, and the vaccination was a vital weapon against COVID-19 in elderly people. In light of the experience of China's COVID-19 response, the measures to improve COVID-19 vaccination coverage in older people were shown as follows: dispatching volunteers into residential communities to urge older people to complete COVID-19 vaccinations; ascertaining the vaccination status of elderly people suffering from underlying diseases; mobilizing various public institutions to participate in COVID-19 response; releasing a great deal of news via mass media every day to educate the elderly about COVID-19 prevention and control measures; assisting elderly people in rural and remote areas through drug distribution and emergency reserves. |
doi_str_mv | 10.1080/21645515.2023.2229704 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2836293569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c199f832f4044ebdb5fe1df3e5a328a8</doaj_id><sourcerecordid>2836293569</sourcerecordid><originalsourceid>FETCH-LOGICAL-c535t-582285a5a54c3156923240364863d93ff0ccb0c3841ca34894843df91371b8f93</originalsourceid><addsrcrecordid>eNp9Uk1vGyEQRVWrJnLzE1px7MUuMLCGk1s5bWMpUi79uiGWBZtod9nC2pH_fXHtWIlUFQ6gmffezMBD6C0lM0ok-cBoxYWgYsYIgxljTM0Jf4EuD_GpEPzXy_Odigt0lfM9KWtOGK-q1-gC5hyAM3WJdj83exwyDiPunXU5m7THY8ShG1LcOby8-7G6nlKFd8ba0JsxxB7bkklm7XDocWwbl_Dg4tC6Bb6JD0_Z48b9k7h4g15502Z3dTon6PuXz9-WN9Pbu6-r5afbqRUgxqmQjElhyuYWqKgUA8YJVFxW0CjwnlhbEwuSU2uAS8Ulh8YrCnNaS69gglZH3Saaez2k0JX5dDRB_w3EtNYmjcG2TluqlJfAPCecu7qphXe08eCEASaNLFqLo9awrTvXWNePybTPRJ9n-rDR67jTlEB58NLUBL0_KaT4e-vyqLuQrWtb07u4zZpJqJiCMmeBiiPUpphzcv5chxJ98IB-9IA-eECfPFB47542eWY9_ngBfDwCQu9j6sxDTG2jR7NvY_LJ9DZkDf-v8QdfF8Ap</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2836293569</pqid></control><display><type>article</type><title>Why is it necessary to improve COVID-19 vaccination coverage in older people? How to improve the vaccination coverage?</title><source>PubMed Central Free</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Access via Taylor & Francis (Open Access Collection)</source><source>Alma/SFX Local Collection</source><creator>Zhu, Ke-Wei</creator><creatorcontrib>Zhu, Ke-Wei</creatorcontrib><description>In accordance with the COVID-19 surveillance data from Hong Kong, over 95% fatal cases were elderly patients aged ≥60 years, and the median age of the dead cases was 86 years in the fifth COVID-19 wave. COVID-19 case fatality rates increased with age, vaccinations offered notable protection against COVID-19 death, and the protection was enhanced as the doses of vaccinations increased. The data fully demonstrated that elderly people were the main group of victims in the COVID-19 pandemic, and the vaccination was a vital weapon against COVID-19 in elderly people. In light of the experience of China's COVID-19 response, the measures to improve COVID-19 vaccination coverage in older people were shown as follows: dispatching volunteers into residential communities to urge older people to complete COVID-19 vaccinations; ascertaining the vaccination status of elderly people suffering from underlying diseases; mobilizing various public institutions to participate in COVID-19 response; releasing a great deal of news via mass media every day to educate the elderly about COVID-19 prevention and control measures; assisting elderly people in rural and remote areas through drug distribution and emergency reserves.</description><identifier>ISSN: 2164-5515</identifier><identifier>EISSN: 2164-554X</identifier><identifier>DOI: 10.1080/21645515.2023.2229704</identifier><identifier>PMID: 37433429</identifier><language>eng</language><publisher>United States: Taylor & Francis</publisher><subject>Aged ; Aged, 80 and over ; China ; Coronavirus ; COVID-19 ; COVID-19 - prevention & control ; COVID-19 Vaccines ; elderly ; Humans ; Pandemics ; Vaccination ; Vaccination Coverage ; zero-COVID-19</subject><ispartof>Human vaccines & immunotherapeutics, 2023-08, Vol.19 (2), p.2229704-2229704</ispartof><rights>2023 The Author(s). Published with license by Taylor & Francis Group, LLC. 2023</rights><rights>2023 The Author(s). Published with license by Taylor & Francis Group, LLC. 2023 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c535t-582285a5a54c3156923240364863d93ff0ccb0c3841ca34894843df91371b8f93</citedby><cites>FETCH-LOGICAL-c535t-582285a5a54c3156923240364863d93ff0ccb0c3841ca34894843df91371b8f93</cites><orcidid>0000-0002-2138-271X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337491/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337491/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,27507,27929,27930,53796,53798,59148,59149</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37433429$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhu, Ke-Wei</creatorcontrib><title>Why is it necessary to improve COVID-19 vaccination coverage in older people? How to improve the vaccination coverage?</title><title>Human vaccines & immunotherapeutics</title><addtitle>Hum Vaccin Immunother</addtitle><description>In accordance with the COVID-19 surveillance data from Hong Kong, over 95% fatal cases were elderly patients aged ≥60 years, and the median age of the dead cases was 86 years in the fifth COVID-19 wave. COVID-19 case fatality rates increased with age, vaccinations offered notable protection against COVID-19 death, and the protection was enhanced as the doses of vaccinations increased. The data fully demonstrated that elderly people were the main group of victims in the COVID-19 pandemic, and the vaccination was a vital weapon against COVID-19 in elderly people. In light of the experience of China's COVID-19 response, the measures to improve COVID-19 vaccination coverage in older people were shown as follows: dispatching volunteers into residential communities to urge older people to complete COVID-19 vaccinations; ascertaining the vaccination status of elderly people suffering from underlying diseases; mobilizing various public institutions to participate in COVID-19 response; releasing a great deal of news via mass media every day to educate the elderly about COVID-19 prevention and control measures; assisting elderly people in rural and remote areas through drug distribution and emergency reserves.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>China</subject><subject>Coronavirus</subject><subject>COVID-19</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 Vaccines</subject><subject>elderly</subject><subject>Humans</subject><subject>Pandemics</subject><subject>Vaccination</subject><subject>Vaccination Coverage</subject><subject>zero-COVID-19</subject><issn>2164-5515</issn><issn>2164-554X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNp9Uk1vGyEQRVWrJnLzE1px7MUuMLCGk1s5bWMpUi79uiGWBZtod9nC2pH_fXHtWIlUFQ6gmffezMBD6C0lM0ok-cBoxYWgYsYIgxljTM0Jf4EuD_GpEPzXy_Odigt0lfM9KWtOGK-q1-gC5hyAM3WJdj83exwyDiPunXU5m7THY8ShG1LcOby8-7G6nlKFd8ba0JsxxB7bkklm7XDocWwbl_Dg4tC6Bb6JD0_Z48b9k7h4g15502Z3dTon6PuXz9-WN9Pbu6-r5afbqRUgxqmQjElhyuYWqKgUA8YJVFxW0CjwnlhbEwuSU2uAS8Ulh8YrCnNaS69gglZH3Saaez2k0JX5dDRB_w3EtNYmjcG2TluqlJfAPCecu7qphXe08eCEASaNLFqLo9awrTvXWNePybTPRJ9n-rDR67jTlEB58NLUBL0_KaT4e-vyqLuQrWtb07u4zZpJqJiCMmeBiiPUpphzcv5chxJ98IB-9IA-eECfPFB47542eWY9_ngBfDwCQu9j6sxDTG2jR7NvY_LJ9DZkDf-v8QdfF8Ap</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Zhu, Ke-Wei</creator><general>Taylor & Francis</general><general>Taylor & Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2138-271X</orcidid></search><sort><creationdate>20230801</creationdate><title>Why is it necessary to improve COVID-19 vaccination coverage in older people? How to improve the vaccination coverage?</title><author>Zhu, Ke-Wei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c535t-582285a5a54c3156923240364863d93ff0ccb0c3841ca34894843df91371b8f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>China</topic><topic>Coronavirus</topic><topic>COVID-19</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 Vaccines</topic><topic>elderly</topic><topic>Humans</topic><topic>Pandemics</topic><topic>Vaccination</topic><topic>Vaccination Coverage</topic><topic>zero-COVID-19</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhu, Ke-Wei</creatorcontrib><collection>Access via Taylor & Francis (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Human vaccines & immunotherapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhu, Ke-Wei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Why is it necessary to improve COVID-19 vaccination coverage in older people? How to improve the vaccination coverage?</atitle><jtitle>Human vaccines & immunotherapeutics</jtitle><addtitle>Hum Vaccin Immunother</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>19</volume><issue>2</issue><spage>2229704</spage><epage>2229704</epage><pages>2229704-2229704</pages><issn>2164-5515</issn><eissn>2164-554X</eissn><abstract>In accordance with the COVID-19 surveillance data from Hong Kong, over 95% fatal cases were elderly patients aged ≥60 years, and the median age of the dead cases was 86 years in the fifth COVID-19 wave. COVID-19 case fatality rates increased with age, vaccinations offered notable protection against COVID-19 death, and the protection was enhanced as the doses of vaccinations increased. The data fully demonstrated that elderly people were the main group of victims in the COVID-19 pandemic, and the vaccination was a vital weapon against COVID-19 in elderly people. In light of the experience of China's COVID-19 response, the measures to improve COVID-19 vaccination coverage in older people were shown as follows: dispatching volunteers into residential communities to urge older people to complete COVID-19 vaccinations; ascertaining the vaccination status of elderly people suffering from underlying diseases; mobilizing various public institutions to participate in COVID-19 response; releasing a great deal of news via mass media every day to educate the elderly about COVID-19 prevention and control measures; assisting elderly people in rural and remote areas through drug distribution and emergency reserves.</abstract><cop>United States</cop><pub>Taylor & Francis</pub><pmid>37433429</pmid><doi>10.1080/21645515.2023.2229704</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-2138-271X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2164-5515 |
ispartof | Human vaccines & immunotherapeutics, 2023-08, Vol.19 (2), p.2229704-2229704 |
issn | 2164-5515 2164-554X |
language | eng |
recordid | cdi_proquest_miscellaneous_2836293569 |
source | PubMed Central Free; MEDLINE; DOAJ Directory of Open Access Journals; Access via Taylor & Francis (Open Access Collection); Alma/SFX Local Collection |
subjects | Aged Aged, 80 and over China Coronavirus COVID-19 COVID-19 - prevention & control COVID-19 Vaccines elderly Humans Pandemics Vaccination Vaccination Coverage zero-COVID-19 |
title | Why is it necessary to improve COVID-19 vaccination coverage in older people? How to improve the vaccination coverage? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T09%3A57%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Why%20is%20it%20necessary%20to%20improve%20COVID-19%20vaccination%20coverage%20in%20older%20people?%20How%20to%20improve%20the%20vaccination%20coverage?&rft.jtitle=Human%20vaccines%20&%20immunotherapeutics&rft.au=Zhu,%20Ke-Wei&rft.date=2023-08-01&rft.volume=19&rft.issue=2&rft.spage=2229704&rft.epage=2229704&rft.pages=2229704-2229704&rft.issn=2164-5515&rft.eissn=2164-554X&rft_id=info:doi/10.1080/21645515.2023.2229704&rft_dat=%3Cproquest_cross%3E2836293569%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2836293569&rft_id=info:pmid/37433429&rft_doaj_id=oai_doaj_org_article_c199f832f4044ebdb5fe1df3e5a328a8&rfr_iscdi=true |